Suite 2, 360 Elizabeth Street
Level 50
Melbourne, VIC 3000
Australia
61 3 9427 7552
https://altheagroupholdings.com
Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno:
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Joshua Michael Fegan | CEO, MD & Executive Director | 824,26k | N/D | N/D |
Mr. Robert Meissner | CFO & Company Secretary | 442,72k | N/D | N/D |
Mr. David Sauer | General Counsel | N/D | N/D | N/D |
Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. It also offers a range of education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name. Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.
L'ISS Governance QualityScore di Althea Group Holdings Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.